The global prefilled syringes market is anticipated to grow at a considerable CAGR of around 9.5% during the forecast period (2021-2027). An increase in the adoption of self-injecting parenteral devices is attributed to driving the global prefilled syringe market. Prefilled are also used as self-injecting devices and it is a modern way to administer parenteral drugs. In addition, they are convenient and help in the administration process. Moreover, prefilled syringe provides greater patient safety and reduces exposure to toxic products. Further, self-injecting devices with their pre-measured dosage reduce dosing errors and increase patient safety and offer multiple advantages to its user. Hence, the above factors attributed to the increase in adoption of self-injecting parenteral devices and inclination towards these products among the healthcare sector and patients will drive the global prefilled syringe market.
Browse the full report description of “Global Prefilled Syringe Market Size, Share & Trends Analysis Report By Material (Glass Based, and Plastic Based) By Design (Single Chamber, Double Chamber, and Customized) By Application (Arthritis, Anaphylaxis , Ophthalmology, Diabetes, Cancer and Others) Forecast Period (2021-2027)” at https://www.omrglobal.com/industry-reports/prefilled-syringe-market
For Instance, in April 2021, Roche announced that the U.S. Food and Drug Administration (FDA) has approved, the biologics license application for Xolair prefilled syringe for self-injection. Moreover, 460,000 patients have been treated in the U.S. with Xolair from its initial approval in 2003. Including 10 Phase III studies Xolair is used across allergic asthma, CIU, and nasal polyps and is based on its well-established efficacy and safety profile and supported by a robust clinical development program.
Market Coverage
• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segment Covered-
o By Material
o By Design
o By Application
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- Becton, Dickinson and Co., Baxter International, Inc., Gerresheimer AG, Pfizer Inc., SCHOTT AG, Terumo Corp., Teva Pharmaceutical Industries Ltd., Ypsomed AG, and others.
Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?
Global Prefilled Syringes Market Report by Segment
• By Design
• By Application
Global Prefilled Syringes Market Report by Region
North America
• US
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/prefilled-syringe-market